GNMK stock forecast
Our latest prediction for GenMark Diagnostics, Inc.'s stock price was made on the Nov. 25, 2019 when the stock price was at 5.56$.
In the short term (2weeks), GNMK's stock price should underperform the market by -6.51%. During that period the price should oscillate between -10.78% and +7.15%.
In the medium term (3months), GNMK's stock price should underperform the market by -15.70%. During that period the price should oscillate between -35.14% and +14.89%.Get email alerts
About GenMark Diagnostics, Inc.
GenMark Diagnostics, Inc. is a molecular diagnostics company, which engages in the provision of multiplex molecular diagnostic solutions. Its products include ePlex and XT-8. The company was founded by Jon Faiz Kayyemin 1993 and is headquartered in Carlsbad, CA.
At the moment the company generates 80M USD in revenues.
On its last earning announcement, the company reported a loss of -0.86$ per share.
The book value per share is 0.89$
Three months stock forecastNov. 25, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|